Ceritinib in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer
Ceritinib was highly active in patients with advanced, ALK-rearranged NSCLC, including those who had had disease progression during crizotinib treatment, regardless of the prese...
Publications
2 shownNCCN Guidelines Insights: Colon Cancer, Version 2.2018
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of r...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,423
- Institution
- Huntsman Cancer Institute
External Links
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.